▟ Vinebot intrinsic value, daily

← back

MET MetLife

insurance · valued with opus medium conviction · deep-dived 2026-10-21

HOLD
Intrinsic value$64.07
Price (at call)$101.18
Margin of safety -36.7%
vs market (rating basis) -10.6%

Quality insurer at 2.3x AOCI-depressed book; the price already assumes mid-teens ROE, leaving little margin of safety.

The story

MetLife is a scaled global life, group benefits and retirement franchise whose earnings increasingly come from fee-like group benefits, Asia, and pension risk transfer, backed by a high-quality but rate-sensitive fixed-income portfolio. Reported book of $28.4B is held down by large AOCI unrealized bond losses, so GAAP ROE of 12.8% understates the economics. Adjusted operating ROE (excluding AOCI) runs in the low-to-mid teens, and GAAP net income is hit by derivative and hedge marks. The company is mid-cycle, with heavy buybacks, solid capital (RBC well above 360%), and the main exposures in commercial real estate loans, private credit, and spread compression if rates fall.

Normalized ROE of 14.5% on reported book sits between trailing GAAP (12.8%) and adjusted operating earnings on the AOCI-depressed book (high teens), discounting non-recurring hedge noise and credit normalization. Book growth stays modest because roughly 60-70% of earnings goes back to shareholders through dividends and buybacks, and terminal growth of 3.5% is below the 5.12% risk-free rate. Beta of 1.0 sits slightly above the 0.9 anchor to reflect leverage and spread-credit exposure.

Value drivers

Return on equity (normalized)14.5%
Book-value growth (Y1)4.0%
Terminal book growth3.5%
Beta1.00
Failure probability1.0%
Cost of equity9.6%

Valuation bridge

PV of excess returns7.37B
PV of terminal excess5.36B
Equity value40.72B
÷ shares → per share$64.07

Projected excess returns on equity

YrBook equityROEExcess returnPV
128.40B 14.5%1.39B 1.27B
229.53B 14.2%1.35B 1.12B
330.70B 13.9%1.30B 988.77M
431.89B 13.5%1.25B 866.34M
533.12B 13.2%1.19B 753.60M
634.37B 12.9%1.13B 650.00M
735.65B 12.6%1.06B 555.01M
836.95B 12.3%975.79M 468.09M
938.29B 11.9%888.38M 388.78M
1039.65B 11.6%792.96M 316.57M

Key risks

  • Commercial real estate and private credit losses in the general account eroding book and ROE
  • Spread compression and lower reinvestment yields if rates fall, offsetting the AOCI recovery
  • Reserve or assumption charges (mortality, morbidity, long-term care legacy) and FX drag on Japan/Latin America

Catalysts

  • AOCI recovery and continued $3B+ annual buybacks lifting per-share book and ROE toward the 15-17% target
  • Growth in pension risk transfer and asset management (MIM) shifting the mix toward capital-light fee earnings

History

DatePriceIntrinsicMoSRating
2026-10-21$101.18 $64.07 -36.7% HOLD
2026-09-18$97.35 $66.43 -31.8% HOLD
2026-08-18$96.68 $62.10 -35.8% HOLD
2026-07-15$92.54 $61.72 -33.3% HOLD
2026-06-23$88.03 $62.34 -29.2% HOLD